Multivariable analysis for cause-specific survival after ILR
| Characteristic | Adjusted HR (95% CI) | P value |
| Age at primary surgery (years)* | 1.13 (0.80 to 1.58) | 0.49 |
| FIGO grade | 0.028 | |
| 1 | Reference | |
| 2–3 | 3.24 (1.13 to 9.25) | |
| LVSI | 0.016 | |
| No | Reference | |
| Yes | 2.10 (1.15 to 3.86) | |
| Treatment of ILR | 0.0499 | |
| Observation or hormonal therapy only | 2.36 (0.90 to 6.14) | |
| Chemotherapy and/or radiotherapy | 2.83 (1.23 to 6.52) | |
| Surgery±other treatments | Reference |
*HR per 10-year increase for age.
FIGO, International Federation of Gynecology and Obstetrics; LVSI, lymphovascular space invasion; ILR, isolated lymphatic recurrence.